$BHC
Bausch Health Companies Inc. Stock $bhc

$bhc Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 8-K Financial Statement

#000088559018000055 Filed on August 10, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$2.163B	$2.219B	$2.233B
YoY Change	-9.99%	-10.49%	-7.73%
Cost Of Revenue	$647.0M	$650.0M	$635.0M
YoY Change	-2.75%	0.15%	-2.01%
Gross Profit	$1.516B	$1.569B	$1.598B
YoY Change	-12.74%	-14.26%	-9.82%
Gross Profit Margin	70.09%	70.71%	71.56%
Selling, General & Admin	$639.0M	$623.0M	$659.0M
YoY Change	-3.91%	-5.75%	-1.79%
% of Gross Profit	42.15%	39.71%	41.24%
Research & Development	$90.00M	$81.00M	$94.00M
YoY Change	-3.02%	-19.8%	-24.19%
% of Gross Profit	5.94%	5.16%	5.88%
Depreciation & Amortization	$819.0M	$698.0M	$667.0M
YoY Change	15.84%	-1.41%	-7.36%
% of Gross Profit	54.02%	44.49%	41.74%
Operating Expenses	$1.506B	$704.0M	$753.0M
YoY Change	32.57%	-7.61%	-5.28%
Operating Profit	-$322.0M	$38.00M	$175.0M
YoY Change	-314.67%	-104.4%	116.05%
Interest Expense	-$425.0M	-$437.0M	-$417.0M
YoY Change	-16.73%	-6.9%	-8.81%
% of Operating Profit		-1150.0%	-238.29%
Other Income/Expense, Net		$325.0M	$19.00M
YoY Change		-32600.0%	-58.7%
Pretax Income	-$804.0M	-$400.0M	-$242.0M
YoY Change	123.27%	-69.97%	-35.81%
Income Tax	-$341.0M	-$1.700B	-$205.0M
% Of Pretax Income
Net Earnings	$513.0M	$1.300B	-$37.00M
YoY Change	-199.69%	-206.64%	-87.83%
Net Earnings / Revenue	23.72%	58.58%	-1.66%
Basic Earnings Per Share	$1.46	$3.71	-$0.11
Diluted Earnings Per Share	$1.45	$3.69	-$0.11
COMMON SHARES
Basic Shares Outstanding	348.6M shares	350.4M shares	350.1M shares
Diluted Shares Outstanding		352.3M shares	350.1M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$720.0M	$964.0M	$1.214B
YoY Change	32.84%	46.28%	42.49%
Cash & Equivalents	$720.0M	$964.0M	$1.214B
Short-Term Investments
Other Short-Term Assets	$848.0M	$1.680B	$1.598B
YoY Change	-11.39%	66.83%	78.15%
Inventory	$1.048B	$1.071B	$1.084B
Prepaid Expenses
Receivables	$2.130B	$2.229B	$2.096B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.746B	$5.944B	$5.992B
YoY Change	-6.52%	4.76%	2.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.403B	$1.398B	$1.373B
YoY Change	6.94%	-4.38%	-6.73%
Goodwill	$15.59B	$15.57B	$15.89B
YoY Change	-1.27%	-10.76%	-14.15%
Intangibles	$15.21B	$16.02B	$17.52B
YoY Change	-19.45%	-21.87%	-17.9%
Long-Term Investments
YoY Change
Other Assets	$111.0M	$152.0M	$111.0M
YoY Change	-39.67%	-28.84%	-49.41%
Total Long-Term Assets	$32.75B	$34.03B	$35.74B
YoY Change	-14.83%	-15.11%	-14.58%
TOTAL ASSETS
Total Short-Term Assets	$4.746B	$5.944B	$5.992B
Total Long-Term Assets	$32.75B	$34.03B	$35.74B
Total Assets	$37.50B	$39.97B	$41.73B
YoY Change	-13.86%	-12.65%	-12.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$365.0M	$407.0M	$371.0M
YoY Change	12.65%	13.47%	-12.89%
Accrued Expenses	$3.694B	$3.396B	$3.259B
YoY Change	14.47%	0.12%	-2.29%
Deferred Revenue
YoY Change
Short-Term Debt	$905.0M	$684.0M	$0.00
YoY Change	14983.33%
Long-Term Debt Due	$209.0M	$925.0M	$813.0M
YoY Change	20800.0%	1467.8%	176.44%
Total Short-Term Liabilities	$4.268B	$4.728B	$4.465B
YoY Change	18.26%	21.33%	5.65%
LONG-TERM LIABILITIES
Long-Term Debt	$25.24B	$26.22B	$27.65B
YoY Change	-15.45%	-13.72%	-10.16%
Other Long-Term Liabilities	$526.0M	$102.0M	$104.0M
YoY Change	8.23%	-38.18%	-38.35%
Total Long-Term Liabilities	$25.76B	$26.32B	$27.75B
YoY Change	-15.07%	-13.86%	-10.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.268B	$4.728B	$4.465B
Total Long-Term Liabilities	$25.76B	$26.32B	$27.75B
Total Liabilities	$31.55B	$34.55B	$37.70B
YoY Change	-21.65%	-16.72%	-10.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.725B	-$3.239B	-$4.539B
YoY Change	-46.87%	-29.8%	32.5%
Common Stock	$10.47B	$10.45B	$10.44B
YoY Change	0.78%	0.9%	1.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.849B	$5.327B	$3.931B
YoY Change
Total Liabilities & Shareholders Equity	$37.50B	$39.97B	$41.73B
YoY Change	-13.86%	-12.65%	-12.44%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$513.0M	$1.300B	-$37.00M
YoY Change	-199.69%	-206.64%	-87.83%
Depreciation, Depletion And Amortization	$819.0M	$698.0M	$667.0M
YoY Change	15.84%	-1.41%	-7.36%
Cash From Operating Activities	$578.0M	$490.0M	$268.0M
YoY Change	12.89%	-13.88%	-40.31%
INVESTING ACTIVITIES
Capital Expenditures	-$72.00M	-$48.00M	-$47.00M
YoY Change	16.13%	-47.25%	-31.88%
Acquisitions
YoY Change
Other Investing Activities	$162.0M	$917.0M	$827.0M
YoY Change	138.24%	4068.18%	594.96%
Cash From Investing Activities	$90.00M	$869.0M	$780.0M
YoY Change	1400.0%	-1359.42%	1460.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.842B	-1.430B	-249.0M
YoY Change	220.35%	105.16%	-73.82%
NET CHANGE
Cash From Operating Activities	$578.0M	$490.0M	$268.0M
Cash From Investing Activities	90.00M	869.0M	780.0M
Cash From Financing Activities	-1.842B	-1.430B	-249.0M
Net Change In Cash	$578.0M	$490.0M	$268.0M
YoY Change	12.89%	-13.88%	-40.31%
FREE CASH FLOW
Cash From Operating Activities	$578.0M	$490.0M	$268.0M
Capital Expenditures	-$72.00M	-$48.00M	-$47.00M
Free Cash Flow	$650.0M	$538.0M	$315.0M
YoY Change	13.24%	-18.48%	-39.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	bhc	Business Acquisition Pro Forma Acquisition Related Costs BusinessAcquisitionProFormaAcquisitionRelatedCosts	35000000	USD
CY2015	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-23000000	USD
CY2016Q4	bhc	Assumed Accrued Professional Feels Legal Liabilities AssumedAccruedProfessionalFeelsLegalLiabilities	281000000	USD
CY2017Q4	bhc	Assumed Accrued Professional Feels Legal Liabilities AssumedAccruedProfessionalFeelsLegalLiabilities	47000000	USD
CY2015	bhc	Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold	130000000	USD
CY2016	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-13000000	USD
CY2017	bhc	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash	-289000000	USD
CY2016Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	897000000	USD
CY2017Q4	bhc	Accrued Product Rebate Current AccruedProductRebateCurrent	1094000000	USD
CY2016Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	708000000	USD
CY2017Q4	bhc	Accrued Product Return Current AccruedProductReturnCurrent	863000000	USD
CY2015	bhc	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	134000000	USD
CY2016	bhc	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	38000000	USD
CY2017	bhc	Acquisition Accounting Adjustment On Inventory Sold AcquisitionAccountingAdjustmentOnInventorySold	0	USD
CY2015Q2	bhc	Allocated Sharebase Compensation Expense Reversal AllocatedSharebaseCompensationExpenseReversal	6000000	USD
CY2015	bhc	Allocated Sharebased Compensation Expense Relatedto Modified Awards AllocatedSharebasedCompensationExpenseRelatedtoModifiedAwards	12000000	USD
CY2015	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	115000000	USD
CY2016	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	174000000	USD
CY2017	bhc	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	119000000	USD
CY2015	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2257000000	USD
CY2016	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2673000000	USD
CY2017	bhc	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	2690000000	USD
CY2016Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	840000000	USD
CY2017Q4	bhc	Business Combination Contingent Consideration Noncurrent Liability BusinessCombinationContingentConsiderationNoncurrentLiability	344000000	USD
CY2017Q4	bhc	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	935000000	USD
CY2017	bhc	Concentration Risk Percentageof Net Trade Receivables ConcentrationRiskPercentageofNetTradeReceivables	0.43
CY2017	bhc	Debt Instrument Redemption Price Percentage Changein Control DebtInstrumentRedemptionPricePercentageChangeinControl	1.01
CY2015	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-160000000	USD
CY2016	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-236000000	USD
CY2017	bhc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-4386000000	USD
CY2016Q4	bhc	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	391000000	USD
CY2017Q4	bhc	Deferred Tax Assets Deferred Expense Deferred Financing And Share Issue Costs DeferredTaxAssetsDeferredExpenseDeferredFinancingAndShareIssueCosts	61000000	USD
CY2016Q4	bhc	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	53000000	USD
CY2017Q4	bhc	Deferred Tax Assets Scientific Research And Experimental Development Pool DeferredTaxAssetsScientificResearchAndExperimentalDevelopmentPool	57000000	USD
CY2016Q4	bhc	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	129000000	USD
CY2017Q4	bhc	Deferred Tax Assets Tax Credit Carryforwards Research And Development DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment	140000000	USD
CY2016Q4	bhc	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	1328000000	USD
CY2017Q4	bhc	Deferred Tax Assets Tax Loss Carryforwards DeferredTaxAssetsTaxLossCarryforwards	2485000000	USD
CY2017	bhc	Deferred Tax Expense Benefit Provisional Deduction For Amended Tax Filing DeferredTaxExpenseBenefitProvisionalDeductionForAmendedTaxFiling	-84000000	USD
CY2016Q4	bhc	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	24000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	542000000	USD
CY2017	bhc	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Adjustments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustments	0	USD
CY2015	bhc	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	23000000	USD
CY2017Q4	bhc	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	18000000	USD
CY2016Q4	bhc	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	80000000	USD
CY2017Q4	bhc	Deferred Tax Liabilities Prepaid Expense DeferredTaxLiabilitiesPrepaidExpense	35000000	USD
CY2017	bhc	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.1
CY2017	bhc	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2015	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	-87000000	USD
CY2016	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	-147000000	USD
CY2017	bhc	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	242000000	USD
CY2017	bhc	Effective Income Tax Rate Reconciliation Changein Deferred Tax Liability Amount EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxLiabilityAmount	1900000000	USD
CY2017Q4	bhc	Estimated Unrecognized Tax Benefits Realized In Next Twelve Months EstimatedUnrecognizedTaxBenefitsRealizedInNextTwelveMonths	0	USD
CY2016	bhc	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification To Held For Sale FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToHeldForSale	26000000	USD
CY2017	bhc	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification To Held For Sale FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToHeldForSale	168000000	USD
CY2016	bhc	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Adjustments FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustments	10000000	USD
CY2016	bhc	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	13000000	USD
CY2017	bhc	Gain Losson Acquisitionrelated Contingent Consideration GainLossonAcquisitionrelatedContingentConsideration	289000000	USD
CY2016	bhc	Gain Losson License Agreement Termination GainLossonLicenseAgreementTermination	20000000	USD
CY2015	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	114000000	USD
CY2016	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	155000000	USD
CY2017	bhc	Income Tax Reconciliation Change In Operating Losses Valuation Allowance IncomeTaxReconciliationChangeInOperatingLossesValuationAllowance	-139000000	USD
CY2015	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-375000000	USD
CY2016	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-399000000	USD
CY2017	bhc	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	-2480000000	USD
CY2015	bhc	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	174000000	USD
CY2016	bhc	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	11000000	USD
CY2017	bhc	Income Tax Reconciliation Foreign Currency Transaction Gain IncomeTaxReconciliationForeignCurrencyTransactionGain	-157000000	USD
CY2015	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	0	USD
CY2016	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	10000000	USD
CY2017	bhc	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	65000000	USD
CY2017	bhc	Maximum Term Of Original Maturity To Classify Instruments As Cash And Cash Equivalents MaximumTermOfOriginalMaturityToClassifyInstrumentsAsCashAndCashEquivalents	P3M
CY2017	bhc	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2015	bhc	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	1696000000	USD
CY2016	bhc	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	0	USD
CY2017	bhc	Noncash Or Part Noncash Acquisition Contingentand Deferred Consideration Obligations NoncashOrPartNoncashAcquisitionContingentandDeferredConsiderationObligations	0	USD
CY2015	bhc	Other Comprehensive Income Loss Foreign Currency Transaction And Translation And Available For Sale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAndAvailableForSaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-647000000	USD
CY2016	bhc	Other Comprehensive Income Loss Foreign Currency Transaction And Translation And Available For Sale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAndAvailableForSaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-548000000	USD
CY2017	bhc	Other Comprehensive Income Loss Foreign Currency Transaction And Translation And Available For Sale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAndAvailableForSaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	202000000	USD
CY2015	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-3000000	USD
CY2016	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-1000000	USD
CY2017	bhc	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-2000000	USD
CY2015	bhc	Other Income Expense Net OtherIncomeExpenseNet	67000000	USD
CY2016	bhc	Other Income Expense Net OtherIncomeExpenseNet	20000000	USD
CY2017	bhc	Other Income Expense Net OtherIncomeExpenseNet	1000000	USD
CY2015	bhc	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	183000000	USD
CY2016	bhc	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	0	USD
CY2017	bhc	Other Post Business Combination Acquisition Related Costs OtherPostBusinessCombinationAcquisitionRelatedCosts	0	USD
CY2016	bhc	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2017	bhc	Past Due Period For Accounts Receivable To Be Negligible PastDuePeriodForAccountsReceivableToBeNegligible	P90D
CY2015	bhc	Paymentof Deferred Consideration PaymentofDeferredConsideration	55000000	USD
CY2016	bhc	Paymentof Deferred Consideration PaymentofDeferredConsideration	540000000	USD
CY2017	bhc	Paymentof Deferred Consideration PaymentofDeferredConsideration	0	USD
CY2017	bhc	Period Receivable Outstanding PeriodReceivableOutstanding	P90D
CY2015	bhc	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	348800000	shares
CY2016	bhc	Potential Weighted Average Number Of Diluted Shares Outstanding PotentialWeightedAverageNumberOfDilutedSharesOutstanding	350100000	shares
CY2015	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	306000000	USD
CY2016	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	385000000	USD
CY2017	bhc	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	328000000	USD
CY2015	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	28000000	USD
CY2016	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	36000000	USD
CY2017	bhc	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	33000000	USD
CY2015	bhc	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	106000000	USD
CY2016	bhc	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	34000000	USD
CY2017	bhc	Research And Development In Process And Other Charges ResearchAndDevelopmentInProcessAndOtherCharges	5000000	USD
CY2015Q1	bhc	Saleof Stock Public Offering Price Per Share SaleofStockPublicOfferingPricePerShare	199.00
CY2015Q1	bhc	Sharebased Compensation Arrangementby Sharebased Payment Award Additional Purchase Optionasa Percentageof Shares Issuedin Ipo Maximum SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalPurchaseOptionasaPercentageofSharesIssuedinIPOMaximum	0.15
CY2017	bhc	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.5
CY2017	bhc	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpenseBenefit	-774000000	USD
CY2017Q4	bhc	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Deferred Tax Liability Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingDeferredTaxLiabilityTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	299000000	USD
CY2017	bhc	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	-975000000	USD
CY2017	bhc	Tax Cutsand Jobs Actof2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Legal Accruals Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetLegalAccrualsProvisionalIncomeTaxExpenseBenefit	10000000	USD
CY2017	bhc	Tax Cutsand Jobs Actof2017 Incomplete Accounting Transition Taxfor Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsandJobsActof2017IncompleteAccountingTransitionTaxforAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	-88000000	USD
CY2016Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	423000000	USD
CY2017Q4	bhc	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	598000000	USD
CY2016	bhc	Unrecognized Tax Benefits Net Increase Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingFromPriorPeriodTaxPositions	63000000	USD
CY2017	bhc	Unrecognized Tax Benefits Net Increase Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingFromPriorPeriodTaxPositions	28000000	USD
CY2016	bhc	Unrecognized Tax Benefits Net Increase Resultingfrom Current Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingfromCurrentPeriodTaxPositions	16000000	USD
CY2017	bhc	Unrecognized Tax Benefits Net Increase Resultingfrom Current Period Tax Positions UnrecognizedTaxBenefitsNetIncreaseResultingfromCurrentPeriodTaxPositions	147000000	USD
CY2017Q4	bhc	Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate	325000000	USD
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	8-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000885590
CY2017	dei	Entity Registrant Name EntityRegistrantName	Bausch Health Companies Inc.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	324000000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	365000000	USD
CY2016Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	198000000	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	259000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	213000000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	202000000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3227000000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3694000000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1196000000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1430000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2108000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1896000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	351000000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	380000000	USD
CY2015	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	88000000	USD
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	11000000	USD
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4000000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165000000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	87000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	57000000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	652000000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	564000000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	462000000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	97000000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	145000000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	118000000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	151000000	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	304000000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	422000000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	714000000	USD
CY2016Q4	us-gaap	Assets Assets	43529000000	USD
CY2017Q4	us-gaap	Assets Assets	37497000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	5077000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	4746000000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	261000000	USD
CY2017Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-1.80
CY2015	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-1.80
CY2015	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-619000000	USD
CY2015	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	10710000000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	23000000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	13000000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	289000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	52000000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	43000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	840000000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	344000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	6000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	2000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	1000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	1000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	1000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	1000000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	597000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	720000000	USD
CY2014Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	323000000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	597000000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	542000000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	797000000	USD
CY2015	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	274000000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55000000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	255000000	USD
CY2015	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2016	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	30000000	USD
CY2017	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2017Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	347821606	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	348708567	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	347821606	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	348708567	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	10038000000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	10090000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-918000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2975000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2617000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-918000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2979000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2621000000	USD
CY2017Q4	us-gaap	Contractual Obligation ContractualObligation	35000000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2532000000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2572000000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2506000000	USD
CY2015	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	53000000	USD
CY2016	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	39000000	USD
CY2017	us-gaap	Cost Of Services Licenses And Services CostOfServicesLicensesAndServices	42000000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	8920000000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	2306000000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	2339000000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	3342000000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	2253000000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	10240000000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	1898000000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	2058000000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	2181000000	USD
CY2017Q4	us-gaap	Costs And Expenses CostsAndExpenses	2485000000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	8622000000	USD
CY2015Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	30000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	77000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	241000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	146000000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	77000000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	241000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	166000000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30169000000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	25752000000	USD
CY2017Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9560000000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	308000000	USD
CY2016Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0575
CY2017Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0607
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	59000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-268000000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-4313000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	146000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	433000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-268000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4311000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6369000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2170000000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5434000000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1180000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	15000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	11000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2938000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3424000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1081000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1423000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	400000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	422000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	59000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	37000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	563000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	589000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1857000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2001000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5288000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	747000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4044000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2014000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	56000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	75000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	2165000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	28000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	28000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	28000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	22000000	USD
CY2015	us-gaap	Depreciation Depreciation	210000000	USD
CY2016	us-gaap	Depreciation Depreciation	193000000	USD
CY2017	us-gaap	Depreciation Depreciation	168000000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2467000000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2866000000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2858000000	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	2132000000	USD
CY2017Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	12000000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.49
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.94
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.71
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.46
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.86
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.49
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.94
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.69
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.45
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.83
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-30000000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-54000000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	41000000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.269
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	57000000	USD
CY2016Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2017Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-13000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-289000000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	-40000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome	1000000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	175000000	USD
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	49000000	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1156000000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	892000000	USD
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	387000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9435000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12122000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1527000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2921000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1851000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2045000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2399000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2684000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	26368000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25549000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16933000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13427000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-103000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-41000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	107000000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-95000000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-14000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	106000000	USD
CY2015	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-42000000	USD
CY2016	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-655000000	USD
CY2017	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-468000000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-5000000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	8000000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	579000000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8000000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	6000000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-37000000	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-37000000	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-59000000	USD
CY2017	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-226000000	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-122000000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	18553000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	15794000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	15593000000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	15794000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1000000	USD
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	286000000	USD
CY2016Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1077000000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	312000000	USD
CY2017Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	USD
CY2016	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	USD
CY2016	us-gaap	Goodwill Transfers GoodwillTransfers	1378000000	USD
CY2017	us-gaap	Goodwill Transfers GoodwillTransfers	175000000	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	5000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1516000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1804000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2032000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1361000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-631000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	291000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-155000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2435000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1741000000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	133000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-27000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4145000000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	230000000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	472000000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	517000000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-747000000	USD
CY2015	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-16000000	USD
CY2016	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	0	USD
CY2017	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-203000000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	107000000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	101000000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-933000000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	377000000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	139000000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4000000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	30000000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	37000000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	24000000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	18000000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-18000000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	95000000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	149000000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	179000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	325000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-144000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	387000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	626000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-417000000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	276000000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164000000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7000000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91000000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-232000000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-33000000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	31000000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	25000000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1600000	shares
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	28319000000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	27333000000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18884000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15211000000	USD
CY2015	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1563000000	USD
CY2016	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1836000000	USD
CY2017	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1840000000	USD
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	14000000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	24000000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	32000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1269000000	USD
CY2016	us-gaap	Interest Paid InterestPaid	1718000000	USD
CY2017	us-gaap	Interest Paid InterestPaid	1708000000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	337000000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	324000000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	680000000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	626000000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	1048000000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	1061000000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	256000000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	276000000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	125000000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	146000000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	8000000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	40271000000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	31553000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43529000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37497000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3609000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4268000000	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	57000000	USD
CY2017Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	57000000	USD
CY2017Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2017Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	243000000	USD
CY2017Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	20000000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	29846000000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	25444000000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1000000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	209000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	14563000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	209000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	5115000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3175000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2690000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29845000000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25235000000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	106000000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	95000000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9000000	USD
CY2017	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	9000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13624000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1963000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4963000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15577000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2887000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2257000000	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	569000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	556000000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	449000000	USD
CY2016Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	512000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2087000000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	954000000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	268000000	USD
CY2017Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	490000000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	578000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2290000000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-292000000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-374000000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-302000000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1218000000	USD
CY2016Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-515000000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2409000000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	628000000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38000000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1301000000	USD
CY2017Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	513000000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2404000000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	3129000000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	5000000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1312000000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1403000000	USD
CY2016	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	1	business
CY2017	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business
CY2017Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	90	country
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1527000000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	66000000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	81000000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-863000000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	150000000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-566000000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	211000000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	175000000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	38000000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-322000000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	102000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	386000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	73000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	37000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	50000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	60000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	132000000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	85000000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	84000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	77000000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	593000000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	905000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	99000000	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-6000000	USD
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	21000000	USD
CY2016	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-32000000	USD
CY2017	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	20000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-26000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	26000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-647000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-548000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	202000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-630000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-571000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	217000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-17000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	23000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-15000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-3000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	4000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-4000000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	486000000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	526000000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	33000000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2000000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	26000000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-295000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-73000000	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-295000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	353000000	USD
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-73000000	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	353000000	USD
CY2015	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	33000000	USD
CY2016	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	69000000	USD
CY2017	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	221000000	USD
CY2015	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	151000000	USD
CY2016	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	123000000	USD
CY2017	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	45000000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	72000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	103000000	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97000000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	110000000	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	18000000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	88000000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15458000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	68000000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	56000000	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	165000000	USD
CY2015	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	49000000	USD
CY2016	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1000000	USD
CY2017	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	7000000	USD
CY2015	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	235000000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	235000000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	171000000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235000000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	171000000	USD
CY2015	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9000000	USD
CY2016	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	9000000	USD
CY2017	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	18000000	USD
CY2016Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	8000000	USD
CY2017Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	7000000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	696000000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	771000000	USD
CY2015	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	184000000	USD
CY2016	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2017	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2015	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	0	USD
CY2016	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	0	USD
CY2017	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	60000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	17817000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1433000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1220000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9424000000	USD
CY2015	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3123000000	USD
CY2016	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2017	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	67000000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	17000000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2000000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13000000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	199000000	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3253000000	USD
CY2015	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8000000	USD
CY2016	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	3000000	USD
CY2017	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33000000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-288000000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-2408000000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	2404000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2508000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2833000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1312000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1403000000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2517000000	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2130000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2055000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2436000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	14203000000	USD
CY2015	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	8000000	USD
CY2016	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3000000	USD
CY2017	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	8000000	USD
CY2016Q2	us-gaap	Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount	0.15
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	334000000	USD
CY2016	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	421000000	USD
CY2017	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	361000000	USD
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	106000000	USD
CY2016	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	34000000	USD
CY2017	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	5000000	USD
CY2015Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77000000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	362000000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	132000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	52000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5129000000	USD
CY2015	us-gaap	Revenues Revenues	10447000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2725000000	USD
CY2016Q1	us-gaap	Revenues Revenues	2372000000	USD
CY2016Q2	us-gaap	Revenues Revenues	2420000000	USD
CY2016Q3	us-gaap	Revenues Revenues	2479000000	USD
CY2016Q4	us-gaap	Revenues Revenues	2403000000	USD
CY2016	us-gaap	Revenues Revenues	9674000000	USD
CY2017Q1	us-gaap	Revenues Revenues	2109000000	USD
CY2017Q2	us-gaap	Revenues Revenues	2233000000	USD
CY2017Q3	us-gaap	Revenues Revenues	2219000000	USD
CY2017Q4	us-gaap	Revenues Revenues	2163000000	USD
CY2017	us-gaap	Revenues Revenues	8724000000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	155000000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	138000000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	129000000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10292000000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9536000000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8595000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2700000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2810000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2582000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	140000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	165000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	87000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2015Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7286432	shares
CY2015Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1450000000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1482000000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	33000000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	72000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	3152000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	5849000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5401000000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6029000000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3258000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5944000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	345000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	344000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	423000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	598000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	39000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	20000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	18000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	39000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	41000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-7000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	16000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	145000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	2000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	23000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	96000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	57000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	5000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	13000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	9000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	185000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	273000000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	342700000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	347300000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	351800000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	342700000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	347300000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350200000	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentrations of Credit Risk </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and trade receivables.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash in high-quality, money market instruments and term deposits with varying maturities, but typically less than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">The Company’s cash and cash equivalents are invested in various investment grade institutional money market accounts and bank term deposits. Deposits held at banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate such risks by spreading its risk across multiple counterparties and monitoring the risk profiles of these counterparties.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s trade receivables primarily represent amounts due from wholesale distributors, retail pharmacies, government entities and group purchasing organizations. Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic regions. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Italy, Portugal, Spain, Greece, among other members of the European Union, Russia, Brazil, and Egypt have been weak in recent years. In November 2016, as a result of the Egyptian government’s decision to float the Egyptian pound and un-peg it to the U.S. Dollar, the Egyptian pound was significantly devalued.  The Company's exposure to the Egyptian pound is with respect to the Amoun Pharmaceutical Company S.A.E. business acquired in October 2015, which represented approximately </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;"> of the Company's 2017 and 2016 total revenues. These conditions have increased, and may continue to increase, the average length of time that it takes to collect on the Company’s trade receivables outstanding in these countries. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An allowance for doubtful accounts is maintained for potential credit losses based on the aging of trade receivables, historical bad debts experience, and changes in customer payment patterns. Trade receivable balances are written off against the allowance when it is deemed probable that the receivable will not be collected.</font></div></div>
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the “Company”) is a multinational, specialty pharmaceutical and medical device company that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices) which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;"> countries. Effective August 9, 2013, the Company continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that the Company became a company registered under the laws of the Province of British Columbia as if it had been incorporated under the laws of the Province of British Columbia. As a result of this continuance, the legal domicile of the Company became the Province of British Columbia, the Canada Business Corporations Act ceased to apply to the Company and the Company became subject to the British Columbia Business Corporations Act.</font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation. </font></div></div>
CY2017	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes product sales revenue when persuasive evidence of an arrangement exists, delivery has occurred, collectability is reasonably assured, and the price to the buyer is fixed or determinable, the timing of which is based on the specific contractual terms with each customer. Delivery occurs when title has transferred to the customer, and the customer has assumed the risks and rewards of ownership. As such, the Company generally recognizes revenue on a sell-in basis (i.e., record revenue upon delivery); however, based upon specific terms and circumstances, the Company has determined that, for certain arrangements with certain retailers and other third parties, revenue should be recognized on a sell-through basis (i.e., record revenue when products are dispensed to patients). In evaluating the proper revenue recognition for sales transactions, the Company considers all relevant factors, including additional discounts or extended payment terms which the Company grants to certain customers, often near the end of quarterly periods.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is recognized net of provisions for estimated cash discounts, allowances, returns, rebates, chargebacks and distribution fees paid to certain of the Company’s wholesale customers. The Company establishes these provisions concurrently with the recognition of product sales revenue.  Price appreciation credits are generated when the Company increases a product’s wholesaler acquisition cost (“WAC”) under its contracts with certain wholesalers. Under such contracts, the Company is entitled to credits from such wholesalers for the impact of that WAC increase on inventory currently on hand at the wholesalers. Such credits, which can be significant, are used to offset against the total distribution service fees the Company pays on all of its products to each wholesaler. Net revenue on these credits is recognized on the date that the wholesaler is notified of the price increase. The Company offers cash discounts for prompt payment and allowances for volume purchases to customers. Provisions for cash discounts and allowances are estimated based on contractual sales terms with customers, an analysis of unpaid invoices, and historical payment experience. The Company generally allows customers to return product within a specified period of time before and after its expiration date, excluding the Company’s European businesses which generally do not carry a right of return. Provisions for returns are estimated based on historical sales and return levels, taking into account additional available information such as historical return and exchange levels, external data with respect to inventory levels in the wholesale distribution channel, external data with respect to prescription demand for the Company’s products, remaining shelf lives of the Company’s products at the date of sale and estimated returns liability to be processed by year of sale based on analysis of lot information related to actual historical returns. The Company reviews its methodology and adequacy of the provision for returns on a quarterly basis, adjusting for changes in assumptions, historical results and business practices, as necessary. The Company is subject to rebates on sales made under governmental and managed-care programs in the U.S., and chargebacks on sales made to government agencies, group purchasing organizations and other indirect customers. Provisions for rebates and chargebacks are estimated based on historical utilization levels, relevant statutes with respect to governmental pricing programs and contractual sales terms with managed-care providers and group purchasing organizations. Changes in the level of utilization of the Company’s products through private or public benefit plans and group purchasing organizations will impact the amount of rebates and chargebacks that the Company is obligated to pay.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is party to product manufacturing and supply agreements with a number of commercialization counterparties in the U.S. Under the terms of these agreements, the Company’s supply prices for its products are determined after taking into consideration estimates for future returns, rebates, and chargebacks provided by each counterparty. The Company makes adjustments, as needed, to state these estimates on a basis consistent with this policy and its methodology for estimating returns, rebates and chargebacks related to its own direct product sales.</font></div></div>

Files In Submission

Name	View Source	Status
0000885590-18-000055-index-headers.html	Edgar Link	pending
0000885590-18-000055-index.html	Edgar Link	pending
0000885590-18-000055.txt	Edgar Link	pending
0000885590-18-000055-xbrl.zip	Edgar Link	pending
bausch20188k.htm	Edgar Link	pending
bausch2018ex23.htm	Edgar Link	pending
bausch2018ex991.htm	Edgar Link	pending
bausch2018ex992.htm	Edgar Link	pending
bhc-20180810.xml	Edgar Link	completed
bhc-20180810.xsd	Edgar Link	pending
bhc-20180810_cal.xml	Edgar Link	unprocessable
bhc-20180810_def.xml	Edgar Link	unprocessable
bhc-20180810_lab.xml	Edgar Link	unprocessable
bhc-20180810_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHC
Bausch Health Companies Inc. Stock $bhc

2017 Q4 Form 8-K Financial Statement

#000088559018000055 Filed on August 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC Bausch Health Companies Inc. Stock $bhc

2017 Q4 Form 8-K Financial Statement

#000088559018000055 Filed on August 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHC
Bausch Health Companies Inc. Stock $bhc